Published on February 25, 2021
Moscow: The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of the Republic of Guatemala.
The vaccine was approved under the emergency use authorization procedure. Guatemala has become the 37th country in the world to approve Sputnik V. The vaccine is one of the world’s top three coronavirus vaccines in terms of the number of approvals issued by government regulators.
Sputnik V had been approved earlier in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt and Honduras.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said:
“Guatemala is the third country of Central America to approve the use of Sputnik V. The safe and effective Russian vaccine is widely recognized around the world as one of the key tools to bring the pandemic to an end soon.”
Sputnik V has a number of key advantages: